Patient Guide: A Study Assessing Esophageal Function and Remodeling With Dupilumab Compared With Placebo for 24 Weeks Followed by 104 Weeks Open Label in Adult Participants With EoE (REMOdeling With Dupilumab in Eosinophilic Esophagitis Long-term Trial)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 30 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06101095
Status: ACTIVE_NOT_RECRUITING
Condition: Eosinophilic Oesophagitis
Phase: PHASE4

Where You Can Participate

This study is available at 30 locations across the country.

Top locations include:
  • • Murrieta, California
  • • San Francisco, California
  • • Jacksonville, Florida
  • • And 27 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study Assessing Esophageal Function and Remodeling With Dupilumab Compared With Placebo for 24 Weeks Followed by 104 Weeks Open Label in Adult Participants With EoE (REMOdeling With Dupilumab in Eosinophilic Esophagitis Long-term Trial) - Join Clinical Trial NCTNCT06101095

How to Join This Clinical Trial - NCTNCT06101095

Learn how to participate in this PHASE4 trial studying an investigational therapy for Eosinophilic Oesophagitis. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Eosinophilic Oesophagitis. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Eosinophilic Oesophagitis
Treatment Being Tested
Investigational treatment
Study Phase
PHASE4 - Research study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT06101095 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 30 locations. Find a study site near you:

Clinical Research Site

Murrieta, California 92563 - United States

Status: Contact for availability

Clinical Research Site

San Francisco, California 94143 - United States

Status: Contact for availability

Clinical Research Site

Jacksonville, Florida 32256 - United States

Status: Contact for availability

Clinical Research Site

Boise, Idaho 83706 - United States

Status: Contact for availability

Clinical Research Site

Chicago, Illinois 60611 - United States

Status: Contact for availability

Clinical Research Site

Glenview, Illinois 60026 - United States

Status: Contact for availability

Clinical Research Site

Gurnee, Illinois 60031 - United States

Status: Contact for availability

Clinical Research Site

Iowa City, Iowa 52242 - United States

Status: Contact for availability

Clinical Research Site

Worcester, Massachusetts 01655 - United States

Status: Contact for availability

Clinical Research Site

Rochester, Minnesota 55905 - United States

Status: Contact for availability

And 20 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE4 clinical trial for Eosinophilic Oesophagitis:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships